McDonald’s Plans China Expansion and 3 Dow Movers Not to Miss

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Johnson & Johnson (NYSE:JNJ): Current price $72.65

Johnson & Johnson said that it will present its Medical Devices & Diagnostics division strategy for accelerating growth during its yearly Business Review. MD&D comprised around 41 percent of the company’s total sales last year. In addition, the firm announced that it is starting an exploratory process through which to examine strategic options for its Ortho Clinical Diagnostics unit. All options will be explored to choose the best opportunity to push future growth and maximize shareholder value. The available options include a possible divestiture if it is determined that OCD could have greater potential as part of another organization whose concentration is more closely aligned with its core strengths, or by being run as a stand-alone entity.

jnj

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business